Literature DB >> 25627015

Irciniastatin A, a pederin-type translation inhibitor, promotes ectodomain shedding of cell-surface tumor necrosis factor receptor 1.

Seiya Hirano1, Hue Tu Quach1, Tsubasa Watanabe2, Naoki Kanoh2, Yoshiharu Iwabuchi2, Takeo Usui3, Takao Kataoka1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25627015     DOI: 10.1038/ja.2015.3

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  16 in total

1.  Antineoplastic agents. 520. Isolation and structure of irciniastatins A and B from the Indo-Pacific marine sponge Ircinia ramosa.

Authors:  George R Pettit; Jun-Ping Xu; Jean-Charles Chapuis; Robin K Pettit; Larry P Tackett; Dennis L Doubek; John N A Hooper; Jean M Schmidt
Journal:  J Med Chem       Date:  2004-02-26       Impact factor: 7.446

2.  Irciniastatin A induces JNK activation that is involved in caspase-8-dependent apoptosis via the mitochondrial pathway.

Authors:  Takumi Chinen; Yoko Nagumo; Tsubasa Watanabe; Takamichi Imaizumi; Masatoshi Shibuya; Takao Kataoka; Naoki Kanoh; Yoshiharu Iwabuchi; Takeo Usui
Journal:  Toxicol Lett       Date:  2010-12-15       Impact factor: 4.372

Review 3.  The psymberin story--biological properties and approaches towards total and analogue syntheses.

Authors:  Max Bielitza; Jörg Pietruszka
Journal:  Angew Chem Int Ed Engl       Date:  2013-09-17       Impact factor: 15.336

4.  Cytotrienin A, a translation inhibitor that induces ectodomain shedding of TNF receptor 1 via activation of ERK and p38 MAP kinase.

Authors:  Yuriko Yamada; Shigeru Taketani; Hiroyuki Osada; Takao Kataoka
Journal:  Eur J Pharmacol       Date:  2011-06-06       Impact factor: 4.432

5.  Inhibition of protein synthesis and activation of stress-activated protein kinases by onnamide A and theopederin B, antitumor marine natural products.

Authors:  Kun-Hyung Lee; Shinichi Nishimura; Shigeki Matsunaga; Nobuhiro Fusetani; Sueharu Horinouchi; Minoru Yoshida
Journal:  Cancer Sci       Date:  2005-06       Impact factor: 6.716

6.  Inhibition of eukaryotic translation elongation by the antitumor natural product Mycalamide B.

Authors:  Yongjun Dang; Tilman Schneider-Poetsch; Daniel E Eyler; John C Jewett; Shridhar Bhat; Viresh H Rawal; Rachel Green; Jun O Liu
Journal:  RNA       Date:  2011-06-21       Impact factor: 4.942

7.  E-73, an acetoxyl analogue of cycloheximide, blocks the tumor necrosis factor-induced NF-kappaB signaling pathway.

Authors:  H Sugimoto; T Kataoka; M Igarashi; M Hamada; T Takeuchi; K Nagai
Journal:  Biochem Biophys Res Commun       Date:  2000-10-22       Impact factor: 3.575

8.  Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.

Authors:  N S Burres; J J Clement
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

9.  Deoxynivalenol induces ectodomain shedding of TNF receptor 1 and thereby inhibits the TNF-α-induced NF-κB signaling pathway.

Authors:  Seiya Hirano; Takao Kataoka
Journal:  Eur J Pharmacol       Date:  2013-01-25       Impact factor: 4.432

10.  ERK and p38 MAP kinase are involved in downregulation of cell surface TNF receptor 1 induced by acetoxycycloheximide.

Authors:  Hirotsugu Ogura; Yoshinori Tsukumo; Hikaru Sugimoto; Masayuki Igarashi; Kazuo Nagai; Takao Kataoka
Journal:  Int Immunopharmacol       Date:  2008-03-18       Impact factor: 4.932

View more
  2 in total

1.  Design, Synthesis, and Evaluation of Irciniastatin Analogues: Simplification of the Tetrahydropyran Core and the C(11) Substituents.

Authors:  Qi Liu; Chihui An; Karen TenDyke; Hongsheng Cheng; Young Yongchun Shen; Adam T Hoye; Amos B Smith
Journal:  J Org Chem       Date:  2016-02-16       Impact factor: 4.354

2.  Reverse of non-small cell lung cancer drug resistance induced by cancer-associated fibroblasts via a paracrine pathway.

Authors:  Quanhui Zhang; Junping Yang; Jie Bai; Jianzhuang Ren
Journal:  Cancer Sci       Date:  2018-03-25       Impact factor: 6.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.